NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma
Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma

NCT01931696

CompletedNA

Sponsor: Shanghai University of Traditional Chinese Medicine

Conditions: Asthma

Interventions: Verum acupuncture, Sham acupuncture

Countries: China

The purpose of this study is to assess whether acupuncture is effective in the treatment of chronic asthma.

Eligibility overview

Sex: ALL

Age: 14 Years to 65 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Patients diagnosed with mild-to-moderate persistent asthma
* Forced expiratory volume in one second (FEV1) reversibility of greater than or equal to 12% following bronchodilator administration (2 puffs)
* Patients who have given written informed consent

Exclusion Criteria:

* Participation in another clinical trial 1 month prior to study entry
* Use of systemic corticosteroids 2 weeks prior to study entry
* Patients with general infection, lower respiratory infection, pulmonary tuberculosis and fungal infection 1 month prior to study entry
* Hospitalization due to acute exacerbation 3 months prior to study entry
* Patients cannot stop using forbidden drugs which include inhaled corticosteroid, theophylline, long-term β2 agonist, sodium cromoglicate, leukotrienes antagonist and anticholinergic drug
* Patients who are allergic to albuterol and corticosteroid
* Patients with severe primary diseases such as cancer, cardiovascular system, liver, kidney and hematopoietic system diseases
* Wheeze caused by pulmonary tuberculosis, bronchiectasia and cardiac insufficiency
* Patients with hyperthyroidism
* Patients with mental illness, acrasia
* Female patients in pregnancy, lactation period and planning to get pregnant during the trial
* Any significant disorder that in the investigator's opinion, might put the patients at risk or influence the study outcomes
* Acupuncture contraindications: serious allergic or infectious dermatitis and hemorrhagic diseases such as thrombocytopenic purpura and hemophilia
Locations (12)
  • Lanzhou, Gansu, China
  • Kaifeng, Henan, China
  • Zhengzhou, Henan, China
  • Zhengzhou, Henan, China
  • Changsha, Hunan, China
  • Shanghai, Shanghai Municipality, China
  • Shanghai, Shanghai Municipality, China
  • Shanghai, Shanghai Municipality, China
  • Shanghai, Shanghai Municipality, China
  • Shanghai, Shanghai Municipality, China
  • Shanghai, Shanghai Municipality, China
  • Wenzhou, Zhejiang, China